Gyre Therapeutics (GYRE) EBT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.10% |
| Dec 31, 2025 | -358.13% |
| Sep 30, 2025 | 240.88% |
| Jun 30, 2025 | -51.72% |
| Mar 31, 2025 | 121.82% |
| Dec 31, 2024 | -640.43% |
| Sep 30, 2024 | -34.88% |
| Jun 30, 2024 | -51.65% |
| Mar 31, 2024 | 112.45% |
| Dec 31, 2023 | -996.30% |
| Sep 30, 2023 | 91.12% |
| Jun 30, 2023 | -6.65% |
| Mar 31, 2023 | 127.50% |
| Dec 31, 2022 | -366.83% |
| Sep 30, 2022 | -109.46% |
| Jun 30, 2022 | 455.20% |
| Mar 31, 2022 | 28.43% |
| Dec 31, 2021 | 19.48% |
| Sep 30, 2021 | -26.72% |
| Jun 30, 2021 | 11.23% |
| Mar 31, 2021 | -14.71% |
| Dec 31, 2020 | -21.91% |
| Sep 30, 2020 | 7.04% |
| Jun 30, 2020 | -264.34% |
| Mar 31, 2020 | 65.01% |
| Dec 31, 2019 | -6.49% |
| Sep 30, 2019 | 7.79% |
| Jun 30, 2019 | 8.64% |
| Mar 31, 2019 | -14.10% |
| Dec 31, 2018 | -71.83% |
| Sep 30, 2018 | -18.14% |
| Jun 30, 2018 | -29.16% |
| Mar 31, 2018 | 15.46% |
| Dec 31, 2017 | -2.95% |
| Sep 30, 2017 | 1.66% |
| Jun 30, 2017 | -42.36% |
| Mar 31, 2017 | -10.35% |
| Dec 31, 2016 | 21.40% |
| Sep 30, 2016 | 1.28% |
| Jun 30, 2016 | -34.55% |
| Mar 31, 2016 | 44.80% |
| Dec 31, 2015 | -80.15% |
| Sep 30, 2015 | 16.70% |
| Jun 30, 2015 | 35.58% |
| Mar 31, 2015 | -45.95% |
| Dec 31, 2014 | 4.89% |
| Sep 30, 2014 | 40.07% |
| Jun 30, 2014 | 30.17% |
| Mar 31, 2014 | 13.26% |
| Dec 31, 2013 | -3.54% |
| Sep 30, 2013 | -4.29% |
| Jun 30, 2013 | -53.37% |
| Mar 31, 2013 | 49.67% |
| Dec 31, 2012 | -103.40% |
| Sep 30, 2012 | -154.37% |
| Jun 30, 2012 | 541.52% |
| Mar 31, 2012 | 123.04% |
| Dec 31, 2011 | -8.29% |
| Sep 30, 2011 | -301.15% |
| Jun 30, 2011 | -117.93% |
| Mar 31, 2011 | 1,318.49% |
| Dec 31, 2010 | -137.66% |
| Sep 30, 2010 | -48.19% |